Camila V. Esguerra

Papers

Total Citations

H-Index

About

Camila V. Esguerra is a pioneering researcher at the forefront of translational oncology and precision medicine, with a primary focus on developing zebrafish xenograft models as predictive tools for cancer therapeutics. Her major contributions center on overcoming a critical bottleneck in the field: the labor-intensive and technically demanding process of microinjecting cancer cells into zebrafish larvae. Through her groundbreaking work on automated microinjection systems, she has dramatically enhanced the reproducibility, throughput, and clinical applicability of these models. Her most cited paper (2025, 5 citations) and its preceding study (2024, 2 citations) demonstrate the growing recognition of her innovations, which promise to transform zebrafish xenografts from a research tool into a viable clinical diagnostic platform. By automating a process that previously required extensive manual expertise, Esguerra’s work enables high-throughput screening of patient-derived cancer cells, paving the way for personalized treatment strategies. Her achievements represent a significant leap in bridging the gap between preclinical models and real-time patient care, positioning her as a key figure in the evolution of cancer diagnostics and drug development.